Search Within

Neuroblastoma Service

  1. "Early Drug Development Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Early Drug Development Service (8)
  4. Pediatrics, Department of (8)
  5. Solid Tumor Oncology Division (8)
  6. Executive Committee, Center for Hematologic Malignancies (7)

More Groups

People
  1. David Hyman (8)
  2. Benjamin Durham (5)
  3. Eli Diamond (5)
  4. Estibaliz Lopez Rodrigo (5)
  5. Marc Ladanyi (5)
  6. Omar Abdel-Wahab (5)

More People

Years
  1. 2020 (2)
  2. 2019 (4)
  3. 2018 (1)
  4. 2017 (1)
Publications
  1. Annals of Oncology (1)
  2. Blood (1)
  3. Cancer Discovery (1)
  4. JCO Precision Oncology (1)
  5. Laboratory Investigation (1)
  6. Modern Pathology (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. American Society of Hematology (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of on-target adverse events caused by TRK inhibitor therapy
    Journal Article

    Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Novel activating mutations in CSF1R and additional kinases with therapeutic implications in histiocytic neoplasms
    Meeting Abstract

    Durham, B.; Picarsic, J.; Lopez-Rodrigo, E.; Hyman, D.; Diamond, E.; Abdel-Wahab, O.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Novel activating mutations in CSF1R and additional kinases with therapeutic implications in histiocytic neoplasms
    Meeting Abstract

    Durham, B.; Picarsic, J.; Lopez-Rodrigo, E.; Hyman, D.; Diamond, E.; Abdel-Wahab, O.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma
    Journal Article

    Shukla, N.; Roberts, S. S.; Baki, M. O.; Mushtaq, Q.; Goss, P. E.; Park, B. H.; Gundem, G.; Tian, K.; Geiger, H.; Redfield, K.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save